App-Quantinova.ai

Temporary Cognitive Impairment in Transient Ischemic Attack and Minor Stroke Patients is Predicted by Chronic White Matter Hyperintensity Volume

Thomas Jeerakathil - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Decreased Internal Cerebral Vein Filling - A New Radiographic Sign of Acute Ischemic Stroke

Apurva Patel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Caveats When Using the CT Perfusion Derived Cerebral Blood Volume Lesion to Help Guide Thrombolysis Treatment in Acute Ischemic Stroke

Enrico Fainardi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Post-Stroke Assessment of Kinaesthesia with and without Vision Using Robotics

Troy Herter - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Factors Affecting Time to Achieve Assigned Blood Pressure Targets in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Leslie A McClure - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypertension

N/A

Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-analysis of Randomized Trials

Robert G Hart - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

Clopidogrel bisulfate

Are Drip and Ship Patients Different than Other rt-PA Treated Patients? Clinical Characteristics and Patient Outcomes

Dawn Kleindorfer - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

The Iscore Predicts Clinical Response to Thrombolysis: Results From VISTA

S. Clayborne Johnston - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

Vista

Granuloctye-Colony Stimulating Factor in Ischemic Stroke Trial (GIST): A Pilot Study

Jenny P Tsai - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ischemic stroke

Filgrastim

Prediction of Intracerebral Hematoma Expansion: Multicenter External Validation of the CTA Spot Sign Score

Andrew Demchuk - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Chinese-Canadian Stroke Patients With Diabetes Display Unique Hypertension Profile: A Ten-year Epidemiology Study

Faculty of Science - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Diabetes

N/A

Intracranial Dolichoectasia in Patients with Recent Lacunar Strokes: The SPS3 Trial

Lesly A Pearce - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

N/A

A Post-Hoc Assessment of Current Hormone Therapy on Revascularization Risk in Women: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)

Ariane Mackey - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

stannous fluoride

Diagnostic Yield of Echocardiography in Patients Presenting with Transient Ischemic Attack

Waimei Tai - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Secular Trends in Ischemic Stroke Subtypes

Daniel G. Hackam - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Correlation between Infarct Shape and Volume and Ischemic Risk Factors and Recurrent Ischemic Rates in Small Subcortical Stroke; Data from the SPS3 Randomized Controlled Trial

Lesley Pearce - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Framingham Stroke Risk Score and Stroke Mortality Among Canadian Adults

Bruce A. Reeder - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left ventricular hypertrophy

N/A

Angiopoietin-1 Mimetic Peptide Treatment of Stroke Regulates MicroRNA Expression and Promotes Neuroprotection in Type One Diabetic Rats

Michael Chopp - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Streptozotocin

Cryptogenic Stroke and Patent Foramen Ovale: Posterior Circulation Strokes Are More Common in Men Than in Women

Robin Ruthazer - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Atrial septal defect

N/A

Early Anti-Coagulation in Acute Cardio-Embolic Stroke is Safe But Does Not Prevent Recurrent Stroke: A Single Centre Review

Michael D Hill - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Deep vein thrombosis

Enoxaparin

Filters

28841 Abstracts